Asthma. Asthma
Conditions
Interventions
Intervention 1: Intervention group: This group received 2 mg of budesonide (Pulmicort Nebuampul 0.5 mg / ml) in a 15-minute period. Intervention 2: The control group received 4 ml of normal saline ser
Sponsors
Sari University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: History of at least 6 months of asthma No need for a ventilator Decrease FEV1, PEF and FEV1 / FVC FEV1 Increase greater than 200 cc or 12% after salbutamol administration in spirometry
Exclusion criteria
Exclusion criteria: The history of infectious diseases such as tuberculosis, recent respiratory infections, bronchiectasis and acute or chronic diarrhea Probability of malignancy based on examination Rheumatic arthritis, degenerative joint disease, vasculitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Forced expiratory volume in 1 second (FEV1). Timepoint: Before prescribing medications, 30 minutes and one hour after administration. Method of measurement: spirometry.;Forced expiratory volume in 1 second (FEV1) / Forced vital capacity (FVC) ratio. Timepoint: Before prescribing medications, 30 minutes and one hour after administration. Method of measurement: spirometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Peak Expiratory Flow Rate. Timepoint: Before prescribing medications, 30 minutes and one hour after administration. Method of measurement: spirometry.;Severity of respiratory distress. Timepoint: Before prescribing medications, 30 minutes and one hour after administration. Method of measurement: spirometry.;Adverse effects. Timepoint: Before prescribing medications, 30 minutes and one hour after administration. Method of measurement: spirometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Hosein Montazer
Sari University of Medical Sciences
Outcome results
None listed